An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access. by Amy V Jones, Darin Curtiss, Claire Harris, Tom Southerington, Marco Hautalahti, Pauli Wihuri, Johanna Mäkelä, Roosa E Kallionpää, Enni Makkonen, Theresa Knopp, Arto Mannermaa, Erna Mäkinen, Anne-Mari Moilanen, Tongalp H Tezel, SCOPE Study group, Nadia K Waheed

Get full text